01-C-0125: A Pilot Study of Non-myeloablative, HLA-matched Allogenic Stem cell Transplantation for Pediatric Hematopoietic Malignancies

Principal Investigator: Alan Wayne

92-C-0137: A Trial of Carboxypeptidase-G2 (CPDG2) for the Management of Patients with Intrathecal Methotrexate Overdose

Principal Investigator: Dr. Brigitte Widemann

04-C-0079: Pediatric Phase I Trial of BL22 for Refractory CD22-Positive Leukemias and Lymphomas

Principal Investigator: Alan Wayne

01-C-0030: Short-Course EPOCH-Rituximab for Untreated CD-20+
HIV-Associated Lymphomas

Principal Investigator: Alan Wayne

04-C-0168: Pediatric Phase I Trial of LMB2 for Refractory CD25-Positive Leukemias and Lymphomas

Principal Investigator: Alan Wayne

05-C-0248: Phase II Study of Campath-1H in Children with Acute Lymphoblastic in Second or Refractory Relapse

Principal Investigator: Elizabeth Fox

06-C-0152: Phase I Trial of AZD2171, an orally bioavailable antiangiogenic agent, in pediatric Patients with refractory or recurrent solid tumors or acute myelogenous leukemia

Principal Investigator: Elizabeth Fox

04-C-0173: Phase II Study Of UCN-01 In Relapsed Or Refractory Systemic Anaplastic Large Cell And Mature T-Cell Lymphomas

Principal Investigator: Alan Wayne

For information regarding clinical trials in leukemia, contact waynea@mail.nih.gov.

Last Updated: :July 26, 2006

NCI Home Page|| NIH Home Page

© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute